| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Emster Kurt Von is a Director at PCVX, with reported holdings spanning 4 companies. Recent filings cover 5 purchases and 47 sales. Those positions are worth an estimated $34.6M at current prices.
Our model assigns Emster Kurt Von a middling insider score of 62/100, based on 3 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of -2.5%.
Emster Kurt Von's largest disclosed position is in CRSP as Director, worth about $34.6M. The recent filings there lean toward selling, a net 1,382,466 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 22,781 | $19.42 | $442,403.40 | -1.1% | |
| Aug 23, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 17,989 | $18.53 | $333,336.17 | -0.9% | |
| Aug 21, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 3,150 | $18.52 | $58,344.50 | -0.2% | |
| Aug 17, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 34,141 | $19.06 | $650,692.78 | -1.6% | |
| Aug 15, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 55,569 | $19.59 | $1,088,560.70 | -2.6% | |
| Aug 8, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 35,473 | $18.63 | $660,887.69 | -1.6% | |
| Aug 4, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 50,477 | $17.81 | $899,215.93 | -2.2% | |
| Aug 1, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 5,512 | $17.51 | $96,491.49 | -0.2% | |
| Jul 28, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 41,312 | $17.63 | $728,134.00 | -1.8% | |
| Jul 26, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 32,930 | $17.60 | $579,545.44 | -1.4% |